GBA1 mutations impair ciliary Hedgehog signaling in Parkinson's disease, reducing neuroprotective factors and highlighting a ...

HNF1A mutations are found to dysregulate RNA splicing in pancreatic cells, thereby contributing to the onset of diabetes.

Mutations in the HNF1A gene impair insulin secretion by disrupting hundreds of genes in β‑cells and causing RNA splicing ...

A groundbreaking study shows that two repurposed cancer drugs, when combined, can correct complex brain cell dysfunction and restore memory ... Existing monoclonal antibodies slow amyloid beta (Aβ) ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

A Harvard team reverses dementia in mice with a metal supplement, after showing that its deficiency drives the disease ...

Even low levels of lead exposure can create permanent changes in brain cells, including increased buildup of abnormal tau and ...

Detailed price information for Inmed Pharmaceuticals Inc (INM-Q) from The Globe and Mail including charting and trades.

The new drug has already passed Phase 1 safety trials in humans, making it a "strong candidate" for future PTSD treatments.

K-Bio showcases AI and protein removal advancements for dementia at Toronto conference Innovations in dementia treatment ...